Chen P M, Tzeng C H, Fan F S, Hsieh R K, Wei C H
Department of Medicine, Veterans General Hospital-Taipei, Taiwan, China.
Bone Marrow Transplant. 1994 Jun;13(6):709-11.
A total of 116 consecutive patients, including 82 cases of hematologic malignancies and 34 cases of severe aplastic anemia (SAA), were treated by allogeneic bone marrow transplantation (BMT). The conditioning regimens and post-graft immunosuppressive agents were as described by Thomas in Seattle and Santos in Baltimore. The incidence of grades II-IV acute GVHD in patients with hematologic malignancies with a full HLA match, with one locus and with two loci mismatches was 6.3% (4 of 63), 0% (0 of 11) and 37.5% (3 of 8), respectively. None of SAA patients developed grade II-IV acute GVHD. The low incidence of acute GVHD after BMT among Chinese patients may be associated with the use of isolation in laminar airflow rooms and a relatively low level of genetic diversity in histocompatibility antigens. This is an interesting issue for further study.
共有116例连续患者接受了异基因骨髓移植(BMT)治疗,其中包括82例血液系统恶性肿瘤患者和34例重型再生障碍性贫血(SAA)患者。预处理方案和移植后免疫抑制剂的使用方法按照西雅图的托马斯和巴尔的摩的桑托斯所描述的进行。在全HLA匹配、一个位点不匹配和两个位点不匹配的血液系统恶性肿瘤患者中,II-IV级急性移植物抗宿主病(GVHD)的发生率分别为6.3%(63例中的4例)、0%(11例中的0例)和37.5%(8例中的3例)。没有SAA患者发生II-IV级急性GVHD。中国患者BMT后急性GVHD的低发生率可能与在层流空气病房中采用隔离措施以及组织相容性抗原中相对较低的遗传多样性水平有关。这是一个值得进一步研究的有趣问题。